The inhibition of apoptosis in EL4 lymphoma cells overexpressing growth hormone

NeuroImmunoModulation

Volumn 11, Issue 3, 2004, Pages 149-159

  Arnold, Robyn E ^a   Weigent, Douglas A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Akt kinase overexpression; Apoptosis; Growth hormone; Lymphoma

Indexed keywords

AGAROSE; CASPASE 2; CASPASE 3; CASPASE 6; CASPASE 8; CASPASE 9; COMPLEMENTARY DNA; DNA FRAGMENT; GROWTH HORMONE; GROWTH HORMONE ANTIBODY; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESYLIC ACID METHYL ESTER; NITRIC OXIDE; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA MICROARRAY; GENE OVEREXPRESSION; HORMONE ACTION; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T CELL LYMPHOMA; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; CARRIER PROTEINS; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; DNA FRAGMENTATION; GLYCOGEN SYNTHASE KINASE 3; GROWTH HORMONE; LYMPHOMA; METHYL METHANESULFONATE; MICE; NF-KAPPA B; NITRIC OXIDE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; STRESS; T-LYMPHOCYTES;

EID: 1842611115     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076764     Document Type: Article

References (54)

1. Weigent DA: Growth hormone and insulin-like growth factor-1 production by cells of the immune system; in Matera L, Rapaport R (eds): Growth and Lactogenic Hormones. New York, Elsevier, 2002, pp 87-100.
2. Weigent DA, Baxter JB, Wear WE, Smith LR, Bost KL, Blalock JE: Production of immunoreactive growth hormone by mononuclear leukocytes. FASEB J 1988;2:2812-2818.
3. Lytras A, Quan N, Vrontakis ME, Shaw JE, Cattini PA, Friesen HG: Growth hormone expression in human Burkitt lymphoma serumfree Ramos cell line. Endocrinology 1993;132:620-628.
4. Rohn WM, Weigent DA: Cloning and nucleotide sequencing of rat lymphocyte growth hormone cDNA. Neuroimmunomodulation 1995;2:108-114.
5. Weigent DA, Baxter JB, Blalock JE: The production of growth hormone and insulin-like growth factor-I by the same subpopulation of rat mononuclear leukocytes. Brain Behav Immun 1992;6:365-376.
6. Weigent DA, Blalock JE: The production of growth hormone by subpopulations of rat mononuclear leukocytes. Cell Immunol 1991;135:55-65.
7. Weigent DA, Blalock JE, LeBoeuf RD: An antisense oligodeoxynucleotide to growth hormone messenger ribonucleic acid inhibits lymphocyte proliferation. Endocrinology 1991;128:2053-2057.
8. Baxter JB, Blalock JE, Weigent DA: Characterization of immunoreactive insulin-like growth factor-I from leukocytes and its regulation by growth hormone. Endocrinology 1991;129:1727-1734.
9. Weigent DA: Immunoregulatory properties of growth hormone and prolactin. J Pharmacol Ther 1996;69:237-257.
10. 2. J Immunol 1995;154:1909-1918.
11. Spadoni GL, Spagnoli A, Cianfarani S, Del Principe D, Menichelli A, DiGiulio S, Boscherini B: Enhancement by growth hormone of phorbol diester-stimulated respiratory burst in human polymorphonuclear leukocytes. Acta Endocrinol 1991;124:589-594.
12. Fu YK, Arkins S, Wang BS, Kelley KW: A novel role of growth hormone and insulin-like growth factor: Priming neutrophils for superoxide anion secretion. J Immunol 1991;146:1602-1608.
13. Wiedermann CJ, Niedermühlbichler M, Geissler D, Beimpold H, Braunsteiner H: Priming of normal human neutrophils by recombinant human growth hormone. Br J Haematol 1991;78:19-22.
14. Clancy RM, Amin AR, Abramson SB: The role of nitric oxide in inflammation and immunity. Arthritis Rheum 1998;41:1141-1151.
15. Dalton TP, Shertzer HG, Puga A: Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol Toxicol 1999;39:39-67.
16. Müller JM, Rupec RA, Baeuerle PA: Study of gene regulation by NF-KB and AP-1 in response to reactive oxygen intermediates. Methods 1998;11:301-312.
17. Kamata H, Hirata H: Redox regulation of cellular signalling. Cell Signal 1999;11:1-14.
18. Baeuerle PA, Henkel T: Function and activation of NF-KB in the immune system. Annu Rev Immunol 1994;12:141-179.
19. Finkel T: Signal transduction by reactive oxygen species in non-phagocytic cells. J Leukoc Biol 1999;65:337-340.
20. Arnold RE, Weigent DA: The production of nitric oxide in EL4 lymphoma cells overexpressing growth hormone. FASEB J 2002;16:A1083.
21. Arnold RE, Weigent DA: The production of nitric oxide in EL4 lymphoma cells overexpressing growth hormone. J Neuroimmunol 2003;134:82-94.
22. Weigent DA, Arnold RE: The inhibition of superoxide production in EL4 lymphoma cells overexpressing growth hormone. FASEB J 2002;16:A396.
23. Matsuda T, Saito H, Inoue T, Fukatsu K, Han I, Furukawa S, Ikeda S, Muto T: Growth hormone inhibits apoptosis and upregulates reactive oxygen intermediate production by human polymorphonuclear neutrophils. J Parenter Enteral Nutr 1998;22:368-374.
24. Jeay S, Sonenshein GE, Postel-Vinay MC, Baixeras E: Growth hormone prevents apoptosis through activation of nuclear factor-kB in interleukin-3-dependent Ba/F3 cell line. Mol Endocrinol 2000;14:650-661.
25. Jeay S, Sonenshein GE, Kelly PA, Postel-Vinay MC, Baixeras E: Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kB and phosphatidylinositol 3-kinase. Endocrinology 2001;142:147-156.
26. Kelly PA, Postel-Vinay MC: The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signaling pathways in the pro-B Ba/F3 cell line. Endocrinology 2001;142:2968-2977.
27. Costoya JA, Finidori J, Moutoussamy S, Senaris R, Devesa J, Arce VM: Activation of growth hormone receptor delivers an antiapoptotic signal: Evidence for a role of Akt in this pathway. Endocrinology 1999;140:5937-5943.
28. Smith GJ, Grisham GW, Fatteh MM: Kinetics of cell death induced in IDT 1/2 cells by methyl methanesulfonate and the effects of extracellular calcium on cell death. Am J Pathol 1986;122:492.
29. Boyd CS, Cadenas E: Nitric oxide and cell signalling pathways in mitochondrial-dependent apoptosis. Biol Chem 2002;383:411-423.
30. Kim YM, Bombeck CA, Billiar TR: Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 1999;84:253-256.
31. Groom LA, Sneddon AA, Alessi DR, Dowd S, Keyse SM: Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO J 1996;15:3621-3632.
32. Brunet A, Bonni A, Zigmond MJ, Lin MA, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999;96:857-868.
33. Cantley LC, Neel BG: New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 1999;96:4240-4245.
34. Pap M, Cooper GM: Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem 1998;273:19929-19932.
35. Kolb JP: Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia. Leukemia 2000;14:1685-1694.
36. Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS: Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 1994;79:1137-1146.
37. Genaro AM, Hortelano S, Alvarez A, Martinez C, Bosca L: Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest 1995;95:1884-1890.
38. Hebestreit H, Dibbert B, Balatti I, Braun D, Schpowal A, Blaser K, Simon HU: Disruption of fas receptor signalling by nitric oxide in eosinophils. J Exp Med 1998;187:415-425.
39. Rossig L, Haendeler J, Hermann C, Malchow P, Urbich C, Zeiher A, Dimmeler S: Nitric oxide downregulates MKP-3 mRNA levels. Involvement in endothelial cell protection from apoptosis. J Biol Chem 2000;275:25502-25507.
40. Kim YM, Talanian RV, Billiar TR: Nitric oxide inhibits apoptosis by preventing increases in caspase-3 activity via two distinct mechanisms. J Biol Chem 1997;272:25502-25507.
41. Dodd F, Limoges M, Boudreau RTM, Murphy PR, Too CKL: L-Arginine inhibits apoptosis via an NO-dependent mechanism in Nb2 lymphoma cells. J Cell Biochem 2000;77:624-634.
42. Zhao H, Dugas N, Mathiot C, Delmer A, Dugas B, Sigaux F, Kolb JP: B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying antiapoptotic activity. Blood 1998;92:1031-1043.
43. Chung HT, Pae HO, Choi BM, Billiar TR, Kim YM: Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 2001;282:1075-1079.
44. Li J, Yang S, Billiar TR: Cyclic nucleotides suppress tumor necrosis factor alpha-mediated apoptosis by inhibiting caspase activation and cytochrome c release in primary hepatocytes via a mechanism independent of Akt activation. J Biol Chem 2000;275:13026-13034.
45. Dimmeler S, Haendeler J, Nehls M, Zeiher AM: Suppression of apoptosis by nitric oxide via inhibition of interleukin-1 beta-converting enzyme (ICE)-like and cysteine protease protein. J Exp Med 1997;185:601-607.
46. Mosser DD, Caron AW, Bourget L, Denis-Larose C, Massie B: Role of the human heat shock protein HSP70 in protection against stress-induced apoptosis. Mol Cell Biol 1997;17:5317-5327.
47. Murphy PR, Limoges M, Dodd F, Boudreau RTM, Too CKL: Fibroblast growth factor-2 stimulates endothelial nitric oxide synthase expression and inhibits apoptosis by a nitric oxide-dependent pathway in Hb2 lymphoma cells. Endocrinology 2001;142:81-88.
48. Yano S, Tokiumitsu H, Soderling TR: Calcium promotes cell survival through CaM-K kinase activation of the protein kinase-B pathway. Nature 1998;396:584-587.
49. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997;91:231-241.
50. King TD, Bijur GN, Jope RS: Caspase-3 activation induced by inhibition of mitochondrial complex 1 is facilitated by glycogen synthase kinase-3β and attenuated by lithium. Brain Res 2001;919:106-114.
51. Somervaille TCP, Linch DC, Khwaja A: Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax. Blood 2001;98:1374-1381.
52. Yamaguchi H, Wang HG: The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 2001;20:7779-7786.
53. Harding PA, Wang X, Okada S, Chen WY, Wan W, Kopchick JJ: Growth hormone (GH) and a GH antagonist promote GH receptor dimerization and internalization. J Biol Chem 2001;271:6708-6712.
54. Kaulsay KK, Zhu T, Bennett WF, Lee K-O, Lobie PE: The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor. Endocrinology 2001;142:767-777.